These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 18686225)
41. Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus. Hsieh CH; He CT; Lee CH; Wu LY; Hung YJ Metabolism; 2007 Aug; 56(8):1087-92. PubMed ID: 17618954 [TBL] [Abstract][Full Text] [Related]
42. Correlation analysis of epicardial adipose tissue thickness, C-reactive protein, interleukin-6, visfatin, juxtaposed with another zinc finger protein 1, and type 2 diabetic macroangiopathy. Gong YY; Peng HY Lipids Health Dis; 2021 Mar; 20(1):25. PubMed ID: 33722242 [TBL] [Abstract][Full Text] [Related]
43. Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus. Takebayashi K; Suetsugu M; Wakabayashi S; Aso Y; Inukai T Metabolism; 2007 Apr; 56(4):451-8. PubMed ID: 17378999 [TBL] [Abstract][Full Text] [Related]
44. Visfatin Levels May be an Early Marker of Atherosclerosis in Patients with Acromegaly. Piskinpasa H; Okuturlar Y; Dogansen SC; Akdeniz YS; Esen A; Sadri S; Pirhan O; Gemici AA; Serin SO; Gedikbası A; Adas M; Mert M Horm Metab Res; 2019 Oct; 51(10):649-654. PubMed ID: 31487747 [TBL] [Abstract][Full Text] [Related]
45. Efficacy and safety of a herbal drug of Coccinia grandis (Linn.) Voigt in patients with type 2 diabetes mellitus: A double blind randomized placebo controlled clinical trial. Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW Phytomedicine; 2021 Jan; 81():153431. PubMed ID: 33352495 [TBL] [Abstract][Full Text] [Related]
46. Effects of one year treatment of sibutramine on insulin resistance parameters in type 2 diabetic patients. Derosa G; Maffioli P; Ferrari I; Palumbo I; Randazzo S; D'Angelo A; Cicero AF J Pharm Pharm Sci; 2010; 13(3):378-90. PubMed ID: 21092710 [TBL] [Abstract][Full Text] [Related]
47. Plasma visfatin and retinol binding protein-4 levels in patients with type 2 diabetes mellitus and their relationship to adiposity and fatty liver. Shaker O; El-Shehaby A; Zakaria A; Mostafa N; Talaat S; Katsiki N; Mikhailidis DP Clin Biochem; 2011 Dec; 44(17-18):1457-63. PubMed ID: 21939650 [TBL] [Abstract][Full Text] [Related]
48. [The effect of liraglutide in combination with human umbilical cord mesenchymal stem cells treatment on glucose metabolism and β cell function in type 2 diabetes mellitus]. Chen P; Huang Q; Xu XJ; Shao ZL; Huang LH; Yang XZ; Guo W; Li CM; Chen C Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):349-54. PubMed ID: 27143183 [TBL] [Abstract][Full Text] [Related]
49. Serum visfatin concentrations in gestational diabetes mellitus and normal pregnancy. Rezvan N; Hosseinzadeh-Attar MJ; Masoudkabir F; Moini A; Janani L; Mazaherioun M Arch Gynecol Obstet; 2012 May; 285(5):1257-62. PubMed ID: 22167446 [TBL] [Abstract][Full Text] [Related]
50. Glycemic variability in inadequately controlled type 1 diabetes and type 2 diabetes on intensive insulin therapy: a cross-sectional, observational study. Greven WL; Beulens JW; Biesma DH; Faiz S; de Valk HW Diabetes Technol Ther; 2010 Sep; 12(9):695-9. PubMed ID: 20687867 [TBL] [Abstract][Full Text] [Related]
51. Evaluation of the Chinese herbal medicine Jinlida in type 2 diabetes patients based on stratification: Results of subgroup analysis from a 12-week trial. Tian J; Lian F; Yang L; Tong X J Diabetes; 2018 Feb; 10(2):112-120. PubMed ID: 28418191 [TBL] [Abstract][Full Text] [Related]
52. Serum visfatin in Asian women with polycystic ovary syndrome. Jongwutiwes T; Lertvikool S; Leelaphiwat S; Rattanasiri S; Jultanmas R; Weerakiet S Gynecol Endocrinol; 2009 Aug; 25(8):536-42. PubMed ID: 19533482 [TBL] [Abstract][Full Text] [Related]
53. Reciprocal changes of serum adispin and visfatin levels in patients with type 2 diabetes after an overnight fast. Legakis I; Mantzouridis T; Bouboulis G; Chrousos GP Arch Endocrinol Metab; 2016 Feb; 60(1):76-8. PubMed ID: 26909486 [TBL] [Abstract][Full Text] [Related]
54. Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: a prospective study. Díaz-Soto G; de Luis DA; Conde-Vicente R; Izaola-Jauregui O; Ramos C; Romero E Diabetes Res Clin Pract; 2014 Apr; 104(1):92-6. PubMed ID: 24530118 [TBL] [Abstract][Full Text] [Related]
55. Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial. Derosa G; Cicero AF; Gaddi AV; Ciccarelli L; Piccinni MN; Salvadeo S; Pricolo F; Fogari E; Ghelfi M; Ferrari I; Fogari R Clin Ther; 2005 Sep; 27(9):1383-91. PubMed ID: 16291411 [TBL] [Abstract][Full Text] [Related]
56. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome? Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743 [TBL] [Abstract][Full Text] [Related]
57. Prediction of type 2 diabetes mellitus using fasting plasma glucose and HbA1c levels among individuals with impaired fasting plasma glucose: a cross-sectional study in Thailand. Sitasuwan T; Lertwattanarak R BMJ Open; 2020 Nov; 10(11):e041269. PubMed ID: 33172945 [TBL] [Abstract][Full Text] [Related]
58. Association Between Triglyceride Level and Glycemic Control Among Insulin-Treated Patients With Type 2 Diabetes. Zheng D; Dou J; Liu G; Pan Y; Yan Y; Liu F; Gaisano HY; Lu J; He Y J Clin Endocrinol Metab; 2019 Apr; 104(4):1211-1220. PubMed ID: 30418583 [TBL] [Abstract][Full Text] [Related]
59. Differential significance of plasma visfatin concentrations according to adiposity in children and adolescents. Kim HJ; Park SY; Choi YJ; Han SJ; Lee KW; Kim DJ Horm Res Paediatr; 2013; 79(4):208-13. PubMed ID: 23615041 [TBL] [Abstract][Full Text] [Related]
60. Impact of rosiglitazone on visfatin and adiponectin plasma concentrations in patients with type 2 diabetes and coronary artery disease. Pfützner A; Marx N; Walcher D; Löbig M; Seidel D; Forst T Clin Lab; 2008; 54(7-8):237-41. PubMed ID: 18942491 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]